Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: September 9, 2025
In today’s Pharmaceutical Executive Daily, we explore strategies to strengthen pharma sales messaging, the role of AI-driven simulations in field rep…
10 months ago
Pharmaceutical Executive Daily: September 8, 2025
In today’s Pharmaceutical Executive Daily, we review the wave of pharmaceutical layoffs shaping 2025, highlight the latest Pharm Exec Top 50 company …
10 months ago
Pharmaceutical Executive Daily: September 5, 2025
In today’s Pharmaceutical Executive Daily, we will recap the top stories of the week, exploring the current state of the GLP-1 market, review major p…
10 months, 1 week ago
Pharmaceutical Executive Daily: September 4, 2025
In today’s Pharmaceutical Executive Daily, we cover political pressure on Moderna and Novavax to release COVID-19 vaccine evidence, a deep dive into …
10 months, 1 week ago
Pharmaceutical Executive Daily: September 3, 2025
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s response to political pressure over COVID-19 vaccine safety data, Cheryl Reicin’s outloo…
10 months, 1 week ago
The Rx for High-Performance Leadership: Cutting Through the Chaos
In a turbulent era for biopharma, leadership demands clarity, resilience, and adaptability. In this candid podcast conversation with Pharm Exec, Ken …
10 months, 3 weeks ago
Pharmaceutical Executive Weekly:CSL Cuts Jobs, Pfizer’s Sickle Cell Setback, and Eli Lilly Expands Zepbound Access
In this week’s Pharmaceutical Executive Weekly, we cover CSL’s decision to cut 15% of its U.S. workforce and close 22 plasma centers, Pfizer’s Phase …
10 months, 3 weeks ago
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis t…
1 year, 3 months ago
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses: The impact of tariffs on the pharmaceutical …
1 year, 3 months ago